We report a case of regression of pulmonary and bony metastases in a patient with malignant melanoma following palliative treatment with systemic zoledronate and localised radiotherapy to the bone. Zoledronate is a potent new bisphosphonate used for the treatment of metabolic bone diseases including...
Détails bibliographiques
| Publié dans: | Clinical immunology (Orlando, Fla.). - 1999. - 131(2009), 3 vom: 15. Juni, Seite 367-73
|
|---|
| Auteur principal: |
Laggner, U
(Auteur) |
|---|
| Autres auteurs: |
Lopez, J S,
Perera, G,
Warbey, V S,
Sita-Lumsden, A,
O'Doherty, M J,
Hayday, A,
Harries, M,
Nestle, F O |
|---|
| Format: | Article en ligne
|
|---|
| Langue: | English |
|---|
| Publié: |
2009
|
|---|
| Accès à la collection: | Clinical immunology (Orlando, Fla.)
|
|---|
| Sujets: | Case Reports
Journal Article
Review
Diphosphonates
Imidazoles
TNF-Related Apoptosis-Inducing Ligand
TNFSF10 protein, human
Zoledronic Acid
6XC1PAD3KF |
|---|